Following an end-of-Phase II meeting with the FDA in the fourth quarter, Viking Therapeutics plans to push its subcutaneous obesity therapy VK2735 into late-stage development and to start a Phase II ...

Viking Therapeutics VKTX is set to report third-quarter earnings on Oct. 23, after market close. Since the company lacks a marketed drug in its portfolio, we do not expect it to record revenues ...

While investigating a Stone Age settlement just outside of Varberg, Sweden, archaeologists serendipitously discovered a massive Viking-Age burial ground rife with artifacts. So far, just six percent ...

Now, a new study finds evidence of how this volcanic event impacted the region of modern-day Denmark, and how the lingering trauma of this prolonged winter possibly made its way into the Viking ...